Download Zipped Amended WordPerfect HB0306.ZIP
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 306

This document includes House Committee Amendments incorporated into the bill on Tue, Feb 15, 2005 at 11:05 AM by ddonat. -->              1     

AMENDMENT REGARDING CONTROLLED

             2     
SUBSTANCES

             3     
2005 GENERAL SESSION

             4     
STATE OF UTAH

             5     
Sponsor: Curtis Oda

             6     
             7      LONG TITLE
             8      General Description:
             9          This bill amends the Controlled Substances Act to clarify the scope of the exception
             10      established for the ceremonial use of peyote by Indians.
             11      Highlighted Provisions:
             12          This bill:
             13          .    provides definitions in the Controlled Substances Act of "Indian," "Indian religion,"
             14      and "Indian tribe" in order to provide for the determination of individuals who are
             15      members of Indian tribes regarding the peyote use exemption; H. [ and ] .H
             16          .    provides a reference to the exemption created by the definitions under the listing of
             17      Schedule I controlled substances H. ; and
             17a          . provides related qualifying language regarding driving with any measurable
             17b      controlled substance in the body .H .
             18      Monies Appropriated in this Bill:
             19          None
             20      Other Special Clauses:
             21          None
             22      Utah Code Sections Affected:
             23      AMENDS:
             23a           H. 41-6a-517, as renumbered and amended by Chapter 2, Laws of Utah 2005 .H
             24          58-37-2, as last amended by Chapter 241, Laws of Utah 2004
             25          58-37-4, as last amended by Chapter 33, Laws of Utah 2003
             26          58-37-8, as last amended by Chapter 36, Laws of Utah 2004


             27     


             28      Be it enacted by the Legislature of the state of Utah:
             28a           H. Section 1. Section 41-6A-517 is amended to read:
             28b          41-6a-517.   Definitions -- Driving with any measurable controlled substance in the body --
             28c      Penalties -- Arrest without warrant.
             28d          (1) As used in this section:
             28e          (a) "Controlled substance" means any substance scheduled under Section 58-37-4.
             28f          (b) "Practitioner" has the same meaning as provided in Section 58-37-2.
             28g          (c) "Prescribe" has the same meaning as provided in Section 58-37-2.
             28h          (d) "Prescription" has the same meaning as provided in Section 58-37-2.
             28i          (2) In cases not amounting to a violation of Section 41-6a-502, a person may not operate or
             28j      be in actual physical control of a motor vehicle within this state if the person has any measurable controlled
             28k      substance or metabolite of a controlled substance in the person's body.
             28l          (3) It is an affirmative defense to prosecution under this section that the controlled substance
             28m      was H. :
             28n          (a) .H involuntarily ingested by the accused H. [ or ] ;
             28o          (b) .H prescribed by a practitioner for use by the accused H. ; or    
             28p          (c) otherwise legally ingested .H .
             28q          (4) A person convicted of a violation of Subsection (2) is guilty of a class B
             28r      misdemeanor.
             28s          (5) A peace officer may, without a warrant, arrest a person for a violation of this
             28t      section when the officer has probable cause to believe the violation has occurred, although not in the
             28u      officer's presence, and if the officer has probable cause to believe that the violation was committed
             28v      by the person.
             28w          (6) The Driver License Division shall:
             28x          (a) suspend, for 90 days, the driver license of a person convicted under Subsection (2);
             28y          (b) revoke, for one year, the driver license of a person convicted of a second or
             28z      subsequent offense under Subsection (2) or if the person has a prior conviction as defined under
             28aa      Subsection 41-6a-501(2), if the violation is committed within a period of ten years after the date of
             28ab      the prior violation; and
             28ac          (c) subtract from any suspension or revocation period the number of days for which a
             28ad      license was previously suspended under Section 53-3-223 or 53-3-231, if the previous suspension
             28ae      was based on the same occurrence upon which the record of conviction is based.
             28af          (7) (a) The court shall notify the Driver License Division if a person fails to:
             28ag          (i) complete all court ordered screening and assessment, educational series, and


             28ah      substance abuse treatment; or
             28ai          (ii) pay all fines and fees, including fees for restitution and treatment costs.
             28aj          (b) Upon receiving the notification, the division shall suspend the person's driving. H


             28ak      H.privilege in accordance with Subsections 53-3-221(2) and (3).
             28al          (8) The court shall order supervised probation in accordance with Section 41-6a-507
             28am      for a person convicted under Subsection (2). . H
             29          Section 1. Section 58-37-2 is amended to read:
             30           58-37-2. Definitions.
             31          (1) As used in this chapter:
             32          (a) "Administer" means the direct application of a controlled substance, whether by
             33      injection, inhalation, ingestion, or any other means, to the body of a patient or research subject
             34      by:
             35          (i) a practitioner or, in his presence, by his authorized agent; or
             36          (ii) the patient or research subject at the direction and in the presence of the
             37      practitioner.
             38          (b) "Agent" means an authorized person who acts on behalf of or at the direction of a
             39      manufacturer, distributor, or practitioner but does not include a motor carrier, public
             40      warehouseman, or employee of any of them.
             41          (c) "Continuing criminal enterprise" means any individual, sole proprietorship,
             42      partnership, corporation, business trust, association, or other legal entity, and any union or
             43      groups of individuals associated in fact although not a legal entity, and includes illicit as well
             44      as licit entities created or maintained for the purpose of engaging in conduct which constitutes
             45      the commission of episodes of activity made unlawful by Title 58, Chapters 37, 37a, 37b, 37c,
             46      or 37d, which episodes are not isolated, but have the same or similar purposes, results,
             47      participants, victims, methods of commission, or otherwise are interrelated by distinguishing
             48      characteristics. Taken together, the episodes shall demonstrate continuing unlawful conduct
             49      and be related either to each other or to the enterprise.
             50          (d) "Control" means to add, remove, or change the placement of a drug, substance, or
             51      immediate precursor under Section 58-37-3 .
             52          (e) (i) "Controlled substance" means a drug or substance included in Schedules I, II, III,
             53      IV, or V of Section 58-37-4 , and also includes a drug or substance included in Schedules I, II,
             54      III, IV, or V of the federal Controlled Substances Act, Title II, P.L. 91-513, or any controlled
             55      substance analog.
             56          (ii) "Controlled substance" does not include:
             57          (A) distilled spirits, wine, or malt beverages, as those terms are defined or used in Title
             58      32A, regarding tobacco or food;



             59          (B) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             60      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             61      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             62      transferred, or furnished as an over-the-counter medication without prescription; or
             63          (C) dietary supplements, vitamins, minerals, herbs, or other similar substances
             64      including concentrates or extracts, which are not otherwise regulated by law, which may
             65      contain naturally occurring amounts of chemical or substances listed in this chapter, or in rules
             66      adopted pursuant to Title 63, Chapter 46a, Utah Administrative Rulemaking Act.
             67          (f) (i) "Controlled substance analog" means a substance the chemical structure of
             68      which is substantially similar to the chemical structure of a controlled substance listed in
             69      Schedules I and II of Section 58-37-4 , or in Schedules I and II of the federal Controlled
             70      Substances Act, Title II, P.L. 91-513:
             71          (A) which has a stimulant, depressant, or hallucinogenic effect on the central nervous
             72      system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central
             73      nervous system of controlled substances in the schedules set forth in this subsection; or
             74          (B) which, with respect to a particular individual, is represented or intended to have a
             75      stimulant, depressant, or hallucinogenic effect on the central nervous system substantially
             76      similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of
             77      controlled substances in the schedules set forth in this Subsection (1).
             78          (ii) "Controlled substance analog" does not include:
             79          (A) a controlled substance currently scheduled in Schedules I through V of Section
             80      58-37-4 ;
             81          (B) a substance for which there is an approved new drug application;
             82          (C) a substance with respect to which an exemption is in effect for investigational use
             83      by a particular person under Section 505 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 366,
             84      to the extent the conduct with respect to the substance is permitted by the exemption;
             85          (D) any substance to the extent not intended for human consumption before an
             86      exemption takes effect with respect to the substance;
             87          (E) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             88      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             89      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,


             90      transferred, or furnished as an over-the-counter medication without prescription; or
             91          (F) dietary supplements, vitamins, minerals, herbs, or other similar substances including
             92      concentrates or extracts, which are not otherwise regulated by law, which may contain naturally
             93      occurring amounts of chemical or substances listed in this chapter, or in rules adopted pursuant
             94      to Title 63, Chapter 46a, Utah Administrative Rulemaking Act.
             95          (g) "Conviction" means a determination of guilt by verdict, whether jury or bench, or
             96      plea, whether guilty or no contest, for any offense proscribed by Title 58, Chapters 37, 37a,
             97      37b, 37c, or 37d, or for any offense under the laws of the United States and any other state
             98      which, if committed in this state, would be an offense under Title 58, Chapters 37, 37a, 37b,
             99      37c, or 37d.
             100          (h) "Counterfeit substance" means:
             101          (i) any substance or container or labeling of any substance that without authorization
             102      bears the trademark, trade name, or other identifying mark, imprint, number, device, or any
             103      likeness of them, of a manufacturer, distributor, or dispenser other than the person or persons
             104      who in fact manufactured, distributed, or dispensed the substance which falsely purports to be a
             105      controlled substance distributed by, any other manufacturer, distributor, or dispenser; or
             106          (ii) any substance that is represented to be a controlled substance.
             107          (i) "Deliver" or "delivery" means the actual, constructive, or attempted transfer of a
             108      controlled substance or a listed chemical, whether or not an agency relationship exists.
             109          (j) "Department" means the Department of Commerce.
             110          (k) "Depressant or stimulant substance" means:
             111          (i) a drug which contains any quantity of barbituric acid or any of the salts of barbituric
             112      acid;
             113          (ii) a drug which contains any quantity of:
             114          (A) amphetamine or any of its optical isomers;
             115          (B) any salt of amphetamine or any salt of an optical isomer of amphetamine; or
             116          (C) any substance which the Secretary of Health and Human Services or the Attorney
             117      General of the United States after investigation has found and by regulation designated
             118      habit-forming because of its stimulant effect on the central nervous system; or
             119          (iii) lysergic acid diethylamide; or
             120          (iv) any drug which contains any quantity of a substance which the Secretary of Health


             121      and Human Services or the Attorney General of the United States after investigation has found
             122      to have, and by regulation designated as having, a potential for abuse because of its depressant
             123      or stimulant effect on the central nervous system or its hallucinogenic effect.
             124          (l) "Dispense" means the delivery of a controlled substance by a pharmacist to an
             125      ultimate user pursuant to the lawful order or prescription of a practitioner, and includes
             126      distributing to, leaving with, giving away, or disposing of that substance as well as the
             127      packaging, labeling, or compounding necessary to prepare the substance for delivery.
             128          (m) "Dispenser" means a pharmacist who dispenses a controlled substance.
             129          (n) "Distribute" means to deliver other than by administering or dispensing a controlled
             130      substance or a listed chemical.
             131          (o) "Distributor" means a person who distributes controlled substances.
             132          (p) "Division" means the Division of Occupational and Professional Licensing created
             133      in Section 58-1-103 .
             134          (q) "Drug" means:
             135          (i) articles recognized in the official United States Pharmacopoeia, Official
             136      Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any
             137      supplement to any of them;
             138          (ii) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention
             139      of disease in man or other animals;
             140          (iii) articles, other than food, intended to affect the structure or function of man or
             141      other animals; and
             142          (iv) articles intended for use as a component of any articles specified in Subsection
             143      (1)(q)(i), (ii), or (iii); but does not include devices or their components, parts, or accessories.
             144          (r) "Drug dependent person" means any individual who unlawfully and habitually uses
             145      any controlled substance to endanger the public morals, health, safety, or welfare, or who is so
             146      dependent upon the use of controlled substances as to have lost the power of self-control with
             147      reference to his dependency.
             148          (s) "Food" means:
             149          (i) any nutrient or substance of plant, mineral, or animal origin other than a drug as
             150      specified in this chapter, and normally ingested by human beings; and
             151          (ii) foods for special dietary uses as exist by reason of a physical, physiological,


             152      pathological, or other condition including but not limited to the conditions of disease,
             153      convalescence, pregnancy, lactation, allergy, hypersensitivity to food, underweight, and
             154      overweight; uses for supplying a particular dietary need which exist by reason of age including
             155      but not limited to the ages of infancy and childbirth, and also uses for supplementing and for
             156      fortifying the ordinary or unusual diet with any vitamin, mineral, or other dietary property for
             157      use of a food. Any particular use of a food is a special dietary use regardless of the nutritional
             158      purposes.
             159          (t) "Immediate precursor" means a substance which the Attorney General of the United
             160      States has found to be, and by regulation designated as being, the principal compound used or
             161      produced primarily for use in the manufacture of a controlled substance, or which is an
             162      immediate chemical intermediary used or likely to be used in the manufacture of a controlled
             163      substance, the control of which is necessary to prevent, curtail, or limit the manufacture of the
             164      controlled substance.
             165          (u) "Indian" means a member of an Indian tribe.
             166          (v) "Indian religion" means any religion:
             167          (i) the origin and interpretation of which is from within a traditional Indian culture or
             168      community; and
             169          (ii) which is practiced by Indians.
             170          (w) "Indian tribe" means any tribe, band, nation, pueblo, or other organized group or
             171      community of Indians, including any Alaska Native village, which is recognized as eligible for
             172      the special programs and services provided by the United States to Indians because of their
             173      status as Indians.
             174          [(u)] (x) "Manufacture" means the production, preparation, propagation, compounding,
             175      or processing of a controlled substance, either directly or indirectly by extraction from
             176      substances of natural origin, or independently by means of chemical synthesis or by a
             177      combination of extraction and chemical synthesis.
             178          [(v)] (y) "Manufacturer" includes any person who packages, repackages, or labels any
             179      container of any controlled substance, except pharmacists who dispense or compound
             180      prescription orders for delivery to the ultimate consumer.
             181          [(w)] (z) "Marijuana" means all species of the genus cannabis and all parts of the
             182      genus, whether growing or not; the seeds of it; the resin extracted from any part of the plant;


             183      and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its
             184      seeds, or resin. The term does not include the mature stalks of the plant, fiber produced from
             185      the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt,
             186      derivative, mixture, or preparation of the mature stalks, except the resin extracted from them,
             187      fiber, oil or cake, or the sterilized seed of the plant which is incapable of germination. Any
             188      synthetic equivalents of the substances contained in the plant cannabis sativa or any other
             189      species of the genus cannabis which are chemically indistinguishable and pharmacologically
             190      active are also included.
             191          [(x)] (aa) "Money" means officially issued coin and currency of the United States or
             192      any foreign country.
             193          [(y)] (bb) "Narcotic drug" means any of the following, whether produced directly or
             194      indirectly by extraction from substances of vegetable origin, or independently by means of
             195      chemical synthesis, or by a combination of extraction and chemical synthesis:
             196          (i) opium, coca leaves, and opiates;
             197          (ii) a compound, manufacture, salt, derivative, or preparation of opium, coca leaves, or
             198      opiates;
             199          (iii) opium poppy and poppy straw; or
             200          (iv) a substance, and any compound, manufacture, salt, derivative, or preparation of the
             201      substance, which is chemically identical with any of the substances referred to in Subsection
             202      (1)(y)(i), (ii), or (iii), except narcotic drug does not include decocainized coca leaves or extracts
             203      of coca leaves which do not contain cocaine or ecgonine.
             204          [(z)] (cc) "Negotiable instrument" means documents, containing an unconditional
             205      promise to pay a sum of money, which are legally transferable to another party by endorsement
             206      or delivery.
             207          [(aa)] (dd) "Opiate" means any drug or other substance having an addiction-forming or
             208      addiction-sustaining liability similar to morphine or being capable of conversion into a drug
             209      having addiction-forming or addiction-sustaining liability.
             210          [(bb)] (ee) "Opium poppy" means the plant of the species papaver somniferum L.,
             211      except the seeds of the plant.
             212          [(cc)] (ff) "Person" means any corporation, association, partnership, trust, other
             213      institution or entity or one or more individuals.


             214          [(dd)] (gg) "Poppy straw" means all parts, except the seeds, of the opium poppy, after
             215      mowing.
             216          [(ee)] (hh) "Possession" or "use" means the joint or individual ownership, control,
             217      occupancy, holding, retaining, belonging, maintaining, or the application, inhalation,
             218      swallowing, injection, or consumption, as distinguished from distribution, of controlled
             219      substances and includes individual, joint, or group possession or use of controlled substances.
             220      For a person to be a possessor or user of a controlled substance, it is not required that he be
             221      shown to have individually possessed, used, or controlled the substance, but it is sufficient if it
             222      is shown that the person jointly participated with one or more persons in the use, possession, or
             223      control of any substances with knowledge that the activity was occurring, or the controlled
             224      substance is found in a place or under circumstances indicating that the person had the ability
             225      and the intent to exercise dominion and control over it.
             226          [(ff)] (ii) "Practitioner" means a physician, dentist, veterinarian, pharmacist, scientific
             227      investigator, pharmacy, hospital, or other person licensed, registered, or otherwise permitted to
             228      distribute, dispense, conduct research with respect to, administer, or use in teaching or
             229      chemical analysis a controlled substance in the course of professional practice or research in
             230      this state.
             231          [(gg)] (jj) "Prescribe" means to issue a prescription orally or in writing.
             232          [(hh)] (kk) "Prescription" means an order issued by a licensed practitioner, in the
             233      course of that practitioner's professional practice, for a controlled substance, other drug, or
             234      device which it dispenses or administers for use by a patient or an animal. The order may be
             235      issued by word of mouth, written document, telephone, facsimile transmission, computer, or
             236      other electronic means of communication as defined by rule.
             237          [(ii)] (ll) "Production" means the manufacture, planting, cultivation, growing, or
             238      harvesting of a controlled substance.
             239          [(jj)] (mm) "Securities" means any stocks, bonds, notes, or other evidences of debt or
             240      of property.
             241          [(kk)] (nn) "State" means the state of Utah.
             242          [(ll)] (oo) "Ultimate user" means any person who lawfully possesses a controlled
             243      substance for his own use, for the use of a member of his household, or for administration to an
             244      animal owned by him or a member of his household.


             245          (2) If a term used in this chapter is not defined, the definition and terms of Title 76,
             246      Utah Criminal Code, shall apply.
             247          Section 2. Section 58-37-4 is amended to read:
             248           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
             249      required -- Specific substances included in schedules.
             250          (1) There are established five schedules of controlled substances known as Schedules I,
             251      II, III, IV, and V which shall consist of substances listed in this section.
             252          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
             253      the official name, common or usual name, chemical name, or brand name designated:
             254          (a) Schedule I:
             255          (i) Unless specifically excepted or unless listed in another schedule, any of the
             256      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             257      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             258      chemical designation:
             259          (A) Acetyl-alpha-methylfentanyl
             260      (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
             261          (B) Acetylmethadol;
             262          (C) Allylprodine;
             263          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             264      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             265          (E) Alphameprodine;
             266          (F) Alphamethadol;
             267          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             268      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine);
             269          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             270      piperidinyl]-N-phenylpropanamide);
             271          (I) Benzethidine;
             272          (J) Betacetylmethadol;
             273          (K) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             274      piperidinyl]-N-phenylpropanamide);
             275          (L) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-


             276      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             277          (M) Betameprodine;
             278          (N) Betamethadol;
             279          (O) Betaprodine;
             280          (P) Clonitazene;
             281          (Q) Dextromoramide;
             282          (R) Diampromide;
             283          (S) Diethylthiambutene;
             284          (T) Difenoxin;
             285          (U) Dimenoxadol;
             286          (V) Dimepheptanol;
             287          (W) Dimethylthiambutene;
             288          (X) Dioxaphetyl butyrate;
             289          (Y) Dipipanone;
             290          (Z) Ethylmethylthiambutene;
             291          (AA) Etonitazene;
             292          (BB) Etoxeridine;
             293          (CC) Furethidine;
             294          (DD) Hydroxypethidine;
             295          (EE) Ketobemidone;
             296          (FF) Levomoramide;
             297          (GG) Levophenacylmorphan;
             298          (HH) Morpheridine;
             299          (II) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             300          (JJ) Noracymethadol;
             301          (KK) Norlevorphanol;
             302          (LL) Normethadone;
             303          (MM) Norpipanone;
             304          (NN) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
             305      propanamide;
             306          (OO) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);


             307          (PP) Phenadoxone;
             308          (QQ) Phenampromide;
             309          (RR) Phenomorphan;
             310          (SS) Phenoperidine;
             311          (TT) Piritramide;
             312          (UU) Proheptazine;
             313          (VV) Properidine;
             314          (WW) Propiram;
             315          (XX) Racemoramide;
             316          (YY) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
             317          (ZZ) Tilidine;
             318          (AAA) Trimeperidine;
             319          (BBB) 3-methylfentanyl, including the optical and geometric isomers
             320      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             321          (CCC) 3-methylthiofentanyl
             322      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             323          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             324      following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
             325      salts, isomers, and salts of isomers is possible within the specific chemical designation:
             326          (A) Acetorphine;
             327          (B) Acetyldihydrocodeine;
             328          (C) Benzylmorphine;
             329          (D) Codeine methylbromide;
             330          (E) Codeine-N-Oxide;
             331          (F) Cyprenorphine;
             332          (G) Desomorphine;
             333          (H) Dihydromorphine;
             334          (I) Drotebanol;
             335          (J) Etorphine (except hydrochloride salt);
             336          (K) Heroin;
             337          (L) Hydromorphinol;


             338          (M) Methyldesorphine;
             339          (N) Methylhydromorphine;
             340          (O) Morphine methylbromide;
             341          (P) Morphine methylsulfonate;
             342          (Q) Morphine-N-Oxide;
             343          (R) Myrophine;
             344          (S) Nicocodeine;
             345          (T) Nicomorphine;
             346          (U) Normorphine;
             347          (V) Pholcodine; and
             348          (W) Thebacon.
             349          (iii) Unless specifically excepted, including the exemption in Subsection 58-37-8 (10),
             350      or unless listed in another schedule, any material, compound, mixture, or preparation which
             351      contains any quantity of the following hallucinogenic substances, or which contains any of
             352      their salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of
             353      isomers is possible within the specific chemical designation; as used in this Subsection (2)(iii)
             354      only, "isomer" includes the optical, position, and geometric isomers:
             355          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             356      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             357          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             358      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             359          (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
             360      2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
             361          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             362      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             363          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             364          (F) 4-methoxyamphetamine, some trade or other names:
             365      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             366          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             367          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
             368      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";


             369          (I) 3,4-methylenedioxy amphetamine;
             370          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             371          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
             372      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             373          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
             374      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             375          (M) 3,4,5-trimethoxy amphetamine;
             376          (N) Bufotenine, some trade and other names:
             377      3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
             378      N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
             379          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             380          (P) Dimethyltryptamine, some trade or other names: DMT;
             381          (Q) Ibogaine, some trade and other names:
             382      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             383      [5,4-b] indole; Tabernanthe iboga;
             384          (R) Lysergic acid diethylamide;
             385          (S) Marijuana;
             386          (T) Mescaline;
             387          (U) Parahexyl, some trade or other names:
             388      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             389          (V) Peyote, meaning all parts of the plant presently classified botanically as
             390      Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
             391      any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
             392      preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             393          (W) N-ethyl-3-piperidyl benzilate;
             394          (X) N-methyl-3-piperidyl benzilate;
             395          (Y) Psilocybin;
             396          (Z) Psilocyn;
             397          (AA) Tetrahydrocannabinols, synthetic equivalents of the substances contained in the
             398      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
             399      and their isomers with similar chemical structure and pharmacological activity such as the


             400      following: .1 cis or trans tetrahydrocannabinol, and their optical isomers .6 cis or trans
             401      tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its
             402      optical isomers, and since nomenclature of these substances is not internationally standardized,
             403      compounds of these structures, regardless of numerical designation of atomic positions
             404      covered;
             405          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             406      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             407      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             408          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             409      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             410          (DD) Thiophene analog of phencyclidine, some trade or other names:
             411      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             412          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
             413          (iv) Unless specifically excepted or unless listed in another schedule, any material
             414      compound, mixture, or preparation which contains any quantity of the following substances
             415      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             416      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             417      specific chemical designation:
             418          (A) Mecloqualone; and
             419          (B) Methaqualone.
             420          (v) Any material, compound, mixture, or preparation containing any quantity of the
             421      following substances having a stimulant effect on the central nervous system, including their
             422      salts, isomers, and salts of isomers:
             423          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             424      4,5-dihydro-5-phenyl-2-oxazolamine;
             425          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
             426      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             427          (C) Fenethylline;
             428          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
             429      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             430      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;


             431      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             432      optical isomers;
             433          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
             434          (F) N-ethylamphetamine; and
             435          (G) N,N-dimethylamphetamine, also known as
             436      N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
             437          (vi) Any material, compound, mixture, or preparation which contains any quantity of
             438      the following substances, including their optical isomers, salts, and salts of isomers, subject to
             439      temporary emergency scheduling:
             440          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             441          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             442          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             443      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
             444      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             445          (b) Schedule II:
             446          (i) Unless specifically excepted or unless listed in another schedule, any of the
             447      following substances whether produced directly or indirectly by extraction from substances of
             448      vegetable origin, or independently by means of chemical synthesis, or by a combination of
             449      extraction and chemical synthesis:
             450          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             451      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             452      and their respective salts, but including:
             453          (I) Raw opium;
             454          (II) Opium extracts;
             455          (III) Opium fluid;
             456          (IV) Powdered opium;
             457          (V) Granulated opium;
             458          (VI) Tincture of opium;
             459          (VII) Codeine;
             460          (VIII) Ethylmorphine;
             461          (IX) Etorphine hydrochloride;


             462          (X) Hydrocodone;
             463          (XI) Hydromorphone;
             464          (XII) Metopon;
             465          (XIII) Morphine;
             466          (XIV) Oxycodone;
             467          (XV) Oxymorphone; and
             468          (XVI) Thebaine;
             469          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             470      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             471      substances may not include the isoquinoline alkaloids of opium;
             472          (C) Opium poppy and poppy straw;
             473          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
             474      any salt, compound, derivative, or preparation which is chemically equivalent or identical with
             475      any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
             476      and salts of isomers and derivatives, whether derived from the coca plant or synthetically
             477      produced, except the substances may not include decocainized coca leaves or extraction of coca
             478      leaves, which extractions do not contain cocaine or ecgonine; and
             479          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             480      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             481          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             482      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             483      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             484      chemical designation, except dextrorphan and levopropoxyphene:
             485          (A) Alfentanil;
             486          (B) Alphaprodine;
             487          (C) Anileridine;
             488          (D) Bezitramide;
             489          (E) Bulk dextropropoxyphene (nondosage forms);
             490          (F) Carfentanil;
             491          (G) Dihydrocodeine;
             492          (H) Diphenoxylate;


             493          (I) Fentanyl;
             494          (J) Isomethadone;
             495          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
             496      levomethadyl acetate, or LAAM;
             497          (L) Levomethorphan;
             498          (M) Levorphanol;
             499          (N) Metazocine;
             500          (O) Methadone;
             501          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             502          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             503      acid;
             504          (R) Pethidine (meperidine);
             505          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
             506          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             507          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             508          (V) Phenazocine;
             509          (W) Piminodine;
             510          (X) Racemethorphan;
             511          (Y) Racemorphan;
             512          (Z) Remifentanil; and
             513          (AA) Sufentanil.
             514          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             515      compound, mixture, or preparation which contains any quantity of the following substances
             516      having a stimulant effect on the central nervous system:
             517          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             518          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
             519          (C) Phenmetrazine and its salts; and
             520          (D) Methylphenidate.
             521          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             522      compound, mixture, or preparation which contains any quantity of the following substances
             523      having a depressant effect on the central nervous system, including its salts, isomers, and salts


             524      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             525      specific chemical designation:
             526          (A) Amobarbital;
             527          (B) Glutethimide;
             528          (C) Pentobarbital;
             529          (D) Phencyclidine;
             530          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             531      1-piperidinocyclohexanecarbonitrile (PCC); and
             532          (F) Secobarbital.
             533          (v) Unless specifically excepted or unless listed in another schedule, any material,
             534      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             535          Some of these substances may be known by trade or other names: phenyl-2-propanone,
             536      P2P; benzyl methyl ketone, methyl benzyl ketone.
             537          (vi) Nabilone, another name for nabilone:
             538      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             539      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             540          (c) Schedule III:
             541          (i) Unless specifically excepted or unless listed in another schedule, any material,
             542      compound, mixture, or preparation which contains any quantity of the following substances
             543      having a stimulant effect on the central nervous system, including its salts, isomers whether
             544      optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
             545      and salts of isomers is possible within the specific chemical designation:
             546          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             547      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
             548      listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
             549      Code of Federal Regulations, and any other drug of the quantitive composition shown in that
             550      list for those drugs or which is the same except that it contains a lesser quantity of controlled
             551      substances;
             552          (B) Benzphetamine;
             553          (C) Chlorphentermine;
             554          (D) Clortermine; and


             555          (E) Phendimetrazine.
             556          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             557      compound, mixture, or preparation which contains any quantity of the following substances
             558      having a depressant effect on the central nervous system:
             559          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
             560      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
             561      which are not listed in any schedule;
             562          (B) Any suppository dosage form containing amobarbital, secobarbital, or
             563      pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
             564      Administration for marketing only as a suppository;
             565          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
             566      salt of any of them;
             567          (D) Chlorhexadol;
             568          (E) Buprenorphine;
             569          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
             570      isomers, and salts of isomers, for which an application is approved under the federal Food,
             571      Drug, and Cosmetic Act, Section 505;
             572          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
             573      . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone.
             574          (H) Lysergic acid;
             575          (I) Lysergic acid amide;
             576          (J) Methyprylon;
             577          (K) Sulfondiethylmethane;
             578          (L) Sulfonethylmethane;
             579          (M) Sulfonmethane; and
             580          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
             581      tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             582      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             583      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
             584      flupyrazapon.
             585          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a


             586      U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             587      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
             588      (-)-delta-9-(trans)-tetrahydrocannabinol.
             589          (iv) Nalorphine.
             590          (v) Unless specifically excepted or unless listed in another schedule, any material,
             591      compound, mixture, or preparation containing limited quantities of any of the following
             592      narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
             593          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             594      milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
             595      opium;
             596          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             597      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             598      therapeutic amounts;
             599          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             600      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
             601      alkaloid of opium;
             602          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             603      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             604      recognized therapeutic amounts;
             605          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             606      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             607      therapeutic amounts;
             608          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
             609      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             610      recognized therapeutic amounts;
             611          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
             612      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             613      recognized therapeutic amounts; and
             614          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
             615      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             616          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids


             617      including any of the following or any isomer, ester, salt, or derivative of the following that
             618      promotes muscle growth:
             619          (A) Boldenone;
             620          (B) Chlorotestosterone (4-chlortestosterone);
             621          (C) Clostebol;
             622          (D) Dehydrochlormethyltestosterone;
             623          (E) Dihydrotestosterone (4-dihydrotestosterone);
             624          (F) Drostanolone;
             625          (G) Ethylestrenol;
             626          (H) Fluoxymesterone;
             627          (I) Formebulone (formebolone);
             628          (J) Mesterolone;
             629          (K) Methandienone;
             630          (L) Methandranone;
             631          (M) Methandriol;
             632          (N) Methandrostenolone;
             633          (O) Methenolone;
             634          (P) Methyltestosterone;
             635          (Q) Mibolerone;
             636          (R) Nandrolone;
             637          (S) Norethandrolone;
             638          (T) Oxandrolone;
             639          (U) Oxymesterone;
             640          (V) Oxymetholone;
             641          (W) Stanolone;
             642          (X) Stanozolol;
             643          (Y) Testolactone;
             644          (Z) Testosterone; and
             645          (AA) Trenbolone.
             646          Anabolic steroids expressly intended for administration through implants to cattle or
             647      other nonhuman species, and approved by the Secretary of Health and Human Services for use,


             648      may not be classified as a controlled substance.
             649          (d) Schedule IV:
             650          (i) Unless specifically excepted or unless listed in another schedule, any material,
             651      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
             652      less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
             653          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             654      compound, mixture, or preparation which contains any quantity of the following substances,
             655      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
             656      salts of isomers is possible within the specific chemical designation:
             657          (A) Alprazolam;
             658          (B) Barbital;
             659          (C) Bromazepam;
             660          (D) Butorphanol;
             661          (E) Camazepam;
             662          (F) Chloral betaine;
             663          (G) Chloral hydrate;
             664          (H) Chlordiazepoxide;
             665          (I) Clobazam;
             666          (J) Clonazepam;
             667          (K) Clorazepate;
             668          (L) Clotiazepam;
             669          (M) Cloxazolam;
             670          (N) Delorazepam;
             671          (O) Diazepam;
             672          (P) Dichloralphenazone;
             673          (Q) Estazolam;
             674          (R) Ethchlorvynol;
             675          (S) Ethinamate;
             676          (T) Ethyl loflazepate;
             677          (U) Fludiazepam;
             678          (V) Flunitrazepam;


             679          (W) Flurazepam;
             680          (X) Halazepam;
             681          (Y) Haloxazolam;
             682          (Z) Ketazolam;
             683          (AA) Loprazolam;
             684          (BB) Lorazepam;
             685          (CC) Lormetazepam;
             686          (DD) Mebutamate;
             687          (EE) Medazepam;
             688          (FF) Meprobamate;
             689          (GG) Methohexital;
             690          (HH) Methylphenobarbital (mephobarbital);
             691          (II) Midazolam;
             692          (JJ) Nimetazepam;
             693          (KK) Nitrazepam;
             694          (LL) Nordiazepam;
             695          (MM) Oxazepam;
             696          (NN) Oxazolam;
             697          (OO) Paraldehyde;
             698          (PP) Pentazocine;
             699          (QQ) Petrichloral;
             700          (RR) Phenobarbital;
             701          (SS) Pinazepam;
             702          (TT) Prazepam;
             703          (UU) Quazepam;
             704          (VV) Temazepam;
             705          (WW) Tetrazepam;
             706          (XX) Triazolam;
             707          (YY) Zaleplon; and
             708          (ZZ) Zolpidem.
             709          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains


             710      any quantity of the following substances, including its salts, isomers whether optical, position,
             711      or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
             712      isomers is possible.
             713          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             714      compound, mixture, or preparation which contains any quantity of the following substances
             715      having a stimulant effect on the central nervous system, including its salts, isomers whether
             716      optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
             717      isomers, and salts of isomers is possible within the specific chemical designation:
             718          (A) Cathine ((+)-norpseudoephedrine);
             719          (B) Diethylpropion;
             720          (C) Fencamfamine;
             721          (D) Fenproprex;
             722          (E) Mazindol;
             723          (F) Mefenorex;
             724          (G) Modafinil;
             725          (H) Pemoline, including organometallic complexes and chelates thereof;
             726          (I) Phentermine;
             727          (J) Pipradrol;
             728          (K) Sibutramine; and
             729          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             730          (v) Unless specifically excepted or unless listed in another schedule, any material,
             731      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             732      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
             733          (e) Schedule V: Any compound, mixture, or preparation containing any of the
             734      following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
             735      base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
             736      sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
             737      qualities other than those possessed by the narcotic drug alone:
             738          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             739          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
             740      grams;


             741          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
             742      grams;
             743          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
             744      atropine sulfate per dosage unit;
             745          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             746          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
             747      atropine sulfate per dosage unit; and
             748          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             749      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
             750      effect on the central nervous system, including its salts, isomers, and salts of isomers.
             751          Section 3. Section 58-37-8 is amended to read:
             752           58-37-8. Prohibited acts -- Penalties.
             753          (1) Prohibited acts A -- Penalties:
             754          (a) Except as authorized by this chapter, it is unlawful for any person to knowingly and
             755      intentionally:
             756          (i) produce, manufacture, or dispense, or to possess with intent to produce,
             757      manufacture, or dispense, a controlled or counterfeit substance;
             758          (ii) distribute a controlled or counterfeit substance, or to agree, consent, offer, or
             759      arrange to distribute a controlled or counterfeit substance;
             760          (iii) possess a controlled or counterfeit substance with intent to distribute; or
             761          (iv) engage in a continuing criminal enterprise where:
             762          (A) the person participates, directs, or engages in conduct which results in any
             763      violation of any provision of Title 58, Chapters 37, 37a, 37b, 37c, or 37d that is a felony; and
             764          (B) the violation is a part of a continuing series of two or more violations of Title 58,
             765      Chapters 37, 37a, 37b, 37c, or 37d on separate occasions that are undertaken in concert with
             766      five or more persons with respect to whom the person occupies a position of organizer,
             767      supervisor, or any other position of management.
             768          (b) Any person convicted of violating Subsection (1)(a) with respect to:
             769          (i) a substance classified in Schedule I or II, a controlled substance analog, or
             770      gammahydroxybutyric acid as listed in Schedule III is guilty of a second degree felony and
             771      upon a second or subsequent conviction is guilty of a first degree felony;


             772          (ii) a substance classified in Schedule III or IV, or marijuana, is guilty of a third degree
             773      felony, and upon a second or subsequent conviction is guilty of a second degree felony; or
             774          (iii) a substance classified in Schedule V is guilty of a class A misdemeanor and upon a
             775      second or subsequent conviction is guilty of a third degree felony.
             776          (c) Any person who has been convicted of a violation of Subsection (1)(a)(ii) or (iii)
             777      may be sentenced to imprisonment for an indeterminate term as provided by law, but if the trier
             778      of fact finds a firearm as defined in Section 76-10-501 was used, carried, or possessed on his
             779      person or in his immediate possession during the commission or in furtherance of the offense,
             780      the court shall additionally sentence the person convicted for a term of one year to run
             781      consecutively and not concurrently; and the court may additionally sentence the person
             782      convicted for an indeterminate term not to exceed five years to run consecutively and not
             783      concurrently.
             784          (d) Any person convicted of violating Subsection (1)(a)(iv) is guilty of a first degree
             785      felony punishable by imprisonment for an indeterminate term of not less than seven years and
             786      which may be for life. Imposition or execution of the sentence may not be suspended, and the
             787      person is not eligible for probation.
             788          (2) Prohibited acts B -- Penalties:
             789          (a) It is unlawful:
             790          (i) for any person knowingly and intentionally to possess or use a controlled substance
             791      analog or a controlled substance, unless it was obtained under a valid prescription or order,
             792      directly from a practitioner while acting in the course of his professional practice, or as
             793      otherwise authorized by this chapter;
             794          (ii) for any owner, tenant, licensee, or person in control of any building, room,
             795      tenement, vehicle, boat, aircraft, or other place knowingly and intentionally to permit them to
             796      be occupied by persons unlawfully possessing, using, or distributing controlled substances in
             797      any of those locations; or
             798          (iii) for any person knowingly and intentionally to possess an altered or forged
             799      prescription or written order for a controlled substance.
             800          (b) Any person convicted of violating Subsection (2)(a)(i) with respect to:
             801          (i) marijuana, if the amount is 100 pounds or more, is guilty of a second degree felony;
             802          (ii) a substance classified in Schedule I or II, marijuana, if the amount is more than 16


             803      ounces, but less than 100 pounds, or a controlled substance analog, is guilty of a third degree
             804      felony; or
             805          (iii) marijuana, if the marijuana is not in the form of an extracted resin from any part of
             806      the plant, and the amount is more than one ounce but less than 16 ounces, is guilty of a class A
             807      misdemeanor.
             808          (c) Upon a second or subsequent conviction of possession of any controlled substance
             809      by a person, that person shall be sentenced to a one degree greater penalty than provided in this
             810      Subsection (2).
             811          (d) Any person who violates Subsection (2)(a)(i) with respect to all other controlled
             812      substances not included in Subsection (2)(b)(i), (ii), or (iii), including less than one ounce of
             813      marijuana, is guilty of a class B misdemeanor. Upon a second conviction the person is guilty
             814      of a class A misdemeanor, and upon a third or subsequent conviction the person is guilty of a
             815      third degree felony.
             816          (e) Any person convicted of violating Subsection (2)(a)(i) while inside the exterior
             817      boundaries of property occupied by any correctional facility as defined in Section 64-13-1 or
             818      any public jail or other place of confinement shall be sentenced to a penalty one degree greater
             819      than provided in Subsection (2)(b), and if the conviction is with respect to controlled
             820      substances as listed in:
             821          (i) Subsection (2)(b), the person may be sentenced to imprisonment for an
             822      indeterminate term as provided by law, and:
             823          (A) the court shall additionally sentence the person convicted to a term of one year to
             824      run consecutively and not concurrently; and
             825          (B) the court may additionally sentence the person convicted for an indeterminate term
             826      not to exceed five years to run consecutively and not concurrently; and
             827          (ii) Subsection (2)(d), the person may be sentenced to imprisonment for an
             828      indeterminate term as provided by law, and the court shall additionally sentence the person
             829      convicted to a term of six months to run consecutively and not concurrently.
             830          (f) Any person convicted of violating Subsection (2)(a)(ii) or (2)(a)(iii) is:
             831          (i) on a first conviction, guilty of a class B misdemeanor;
             832          (ii) on a second conviction, guilty of a class A misdemeanor; and
             833          (iii) on a third or subsequent conviction, guilty of a third degree felony.


             834          (g) A person is subject to the penalties under Subsection (4)(c) who, in an offense not
             835      amounting to a violation of Section 76-5-207 :
             836          (i) violates Subsection (2)(a)(i) by knowingly and intentionally having in his body any
             837      measurable amount of a controlled substance; and
             838          (ii) operates a motor vehicle as defined in Section 76-5-207 in a negligent manner,
             839      causing serious bodily injury as defined in Section 76-1-601 or the death of another.
             840          (3) Prohibited acts C -- Penalties:
             841          (a) It is unlawful for any person knowingly and intentionally:
             842          (i) to use in the course of the manufacture or distribution of a controlled substance a
             843      license number which is fictitious, revoked, suspended, or issued to another person or, for the
             844      purpose of obtaining a controlled substance, to assume the title of, or represent himself to be, a
             845      manufacturer, wholesaler, apothecary, physician, dentist, veterinarian, or other authorized
             846      person;
             847          (ii) to acquire or obtain possession of, to procure or attempt to procure the
             848      administration of, to obtain a prescription for, to prescribe or dispense to any person known to
             849      be attempting to acquire or obtain possession of, or to procure the administration of any
             850      controlled substance by misrepresentation or failure by the person to disclose his receiving any
             851      controlled substance from another source, fraud, forgery, deception, subterfuge, alteration of a
             852      prescription or written order for a controlled substance, or the use of a false name or address;
             853          (iii) to make any false or forged prescription or written order for a controlled substance,
             854      or to utter the same, or to alter any prescription or written order issued or written under the
             855      terms of this chapter; or
             856          (iv) to make, distribute, or possess any punch, die, plate, stone, or other thing designed
             857      to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or
             858      device of another or any likeness of any of the foregoing upon any drug or container or labeling
             859      so as to render any drug a counterfeit controlled substance.
             860          (b) Any person convicted of violating Subsection (3)(a) is guilty of a third degree
             861      felony.
             862          (4) Prohibited acts D -- Penalties:
             863          (a) Notwithstanding other provisions of this section, a person not authorized under this
             864      chapter who commits any act declared to be unlawful under this section, Title 58, Chapter 37a,


             865      Utah Drug Paraphernalia Act, or under Title 58, Chapter 37b, Imitation Controlled Substances
             866      Act, is upon conviction subject to the penalties and classifications under this Subsection (4) if
             867      the trier of fact finds the act is committed:
             868          (i) in a public or private elementary or secondary school or on the grounds of any of
             869      those schools;
             870          (ii) in a public or private vocational school or postsecondary institution or on the
             871      grounds of any of those schools or institutions;
             872          (iii) in those portions of any building, park, stadium, or other structure or grounds
             873      which are, at the time of the act, being used for an activity sponsored by or through a school or
             874      institution under Subsections (4)(a)(i) and (ii);
             875          (iv) in or on the grounds of a preschool or child-care facility;
             876          (v) in a public park, amusement park, arcade, or recreation center;
             877          (vi) in or on the grounds of a house of worship as defined in Section 76-10-501 ;
             878          (vii) in a shopping mall, sports facility, stadium, arena, theater, movie house,
             879      playhouse, or parking lot or structure adjacent thereto;
             880          (viii) in a public parking lot or structure;
             881          (ix) within 1,000 feet of any structure, facility, or grounds included in Subsections
             882      (4)(a)(i) through (viii);
             883          (x) in the immediate presence of a person younger than 18 years of age, regardless of
             884      where the act occurs; or
             885          (xi) for the purpose of facilitating, arranging, or causing the transport, delivery, or
             886      distribution of a substance in violation of this section to an inmate or on the grounds of any
             887      correctional facility as defined in Section 76-8-311.3 .
             888          (b) A person convicted under this Subsection (4) is guilty of a first degree felony and
             889      shall be imprisoned for a term of not less than five years if the penalty that would otherwise
             890      have been established but for this subsection would have been a first degree felony. Imposition
             891      or execution of the sentence may not be suspended, and the person is not eligible for probation.
             892          (c) If the classification that would otherwise have been established would have been
             893      less than a first degree felony but for this Subsection (4), a person convicted under Subsection
             894      (2)(g) or this Subsection (4) is guilty of one degree more than the maximum penalty prescribed
             895      for that offense.


             896          (d) (i) If the violation is of Subsection (4)(a)(xi):
             897          (A) the person may be sentenced to imprisonment for an indeterminate term as
             898      provided by law, and the court shall additionally sentence the person convicted for a term of
             899      one year to run consecutively and not concurrently; and
             900          (B) the court may additionally sentence the person convicted for an indeterminate term
             901      not to exceed five years to run consecutively and not concurrently; and
             902          (ii) the penalties under this Subsection (4)(d) apply also to any person who, acting with
             903      the mental state required for the commission of an offense, directly or indirectly solicits,
             904      requests, commands, coerces, encourages, or intentionally aids another person to commit a
             905      violation of Subsection (4)(a)(xi).
             906          (e) It is not a defense to a prosecution under this Subsection (4) that the actor
             907      mistakenly believed the individual to be 18 years of age or older at the time of the offense or
             908      was unaware of the individual's true age; nor that the actor mistakenly believed that the
             909      location where the act occurred was not as described in Subsection (4)(a) or was unaware that
             910      the location where the act occurred was as described in Subsection (4)(a).
             911          (5) Any violation of this chapter for which no penalty is specified is a class B
             912      misdemeanor.
             913          (6) (a) Any penalty imposed for violation of this section is in addition to, and not in
             914      lieu of, any civil or administrative penalty or sanction authorized by law.
             915          (b) Where violation of this chapter violates a federal law or the law of another state,
             916      conviction or acquittal under federal law or the law of another state for the same act is a bar to
             917      prosecution in this state.
             918          (7) In any prosecution for a violation of this chapter, evidence or proof which shows a
             919      person or persons produced, manufactured, possessed, distributed, or dispensed a controlled
             920      substance or substances, is prima facie evidence that the person or persons did so with
             921      knowledge of the character of the substance or substances.
             922          (8) This section does not prohibit a veterinarian, in good faith and in the course of his
             923      professional practice only and not for humans, from prescribing, dispensing, or administering
             924      controlled substances or from causing the substances to be administered by an assistant or
             925      orderly under his direction and supervision.
             926          (9) Civil or criminal liability may not be imposed under this section on:


             927          (a) any person registered under the Controlled Substances Act who manufactures,
             928      distributes, or possesses an imitation controlled substance for use as a placebo or
             929      investigational new drug by a registered practitioner in the ordinary course of professional
             930      practice or research; or
             931          (b) any law enforcement officer acting in the course and legitimate scope of his
             932      employment.
             933          (10) (a) It is an affirmative defense to a charge of violating Subsection
             934      58-37-4 (2)(a)(iii)(V) that the peyote is used, possessed, or transported by an Indian, as defined
             935      by Subsection 58-37-2 (1)(u), for bona fide traditional ceremonial purposes in connection with
             936      the practice of a traditional Indian religion, as defined by Subsection 58-37-2 (1)(v).
             937          (b) (i) The defendant shall provide written notice of intent to claim an affirmative
             938      defense under this Subsection (10) as soon as practicable, but not later than ten days prior to
             939      trial.
             940          (ii) The court may waive the notice requirement in the interest of justice for good cause
             941      shown, if the prosecutor is not unfairly prejudiced by the lack of timely notice.
             942          (c) The notice shall include the specific claims of the affirmative defense.
             943          (d) The defendant shall establish the affirmative defense under this Subsection (10) by
             944      a preponderance of the evidence. If the defense is established, it is a complete defense to the
             945      charges.
             946          [(10)] (11) If any provision of this chapter, or the application of any provision to any
             947      person or circumstances, is held invalid, the remainder of this chapter shall be given effect
             948      without the invalid provision or application.




Legislative Review Note
    as of 2-1-05 3:17 PM


Based on a limited legal review, this legislation has not been determined to have a high
probability of being held unconstitutional.

Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]